Selected research
Market Outlook & Growth Opportunities
Global Recreational Drug Market Outlook and Growth Opportunities 2026
Market perspective
The global Recreational Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Recreational Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Recreational Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Recreational Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Recreational Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Recreational Drug market include Yunnan Industrial Hemp, Yishutang, Suyash Herbs, Nutiva, North American Hemp & Grain Co, Naturally Splendid, Manitoba Harvest, Jinzhou Qiaopai Biotech and Isodiol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Recreational Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Recreational Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Recreational Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Recreational Drug market size, projected growth trends, production technologies, key applications, and end-use industries.
Recreational Drug Segment by Company
Yunnan Industrial Hemp
Yishutang
Suyash Herbs
Nutiva
North American Hemp & Grain Co
Naturally Splendid
Manitoba Harvest
Jinzhou Qiaopai Biotech
Isodiol
Hempco
GFR Ingredients Inc
ENDOCA
CW Hemp/CW Botanicals
CV Sciences
Canopy Growth Corporation
BAFA neu GmbH
Aphria
Aos Products
Agropro
Recreational Drug Segment by Type
Inhalants
Euphoriants
Stimulants
Depressants
Hallucinogens
Recreational Drug Segment by Application
Supermarkets
Convenience Stores
Others
Recreational Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Recreational Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Recreational Drug market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Recreational Drug significant trends, drivers, influence factors in global and regions.
6. To analyze Recreational Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recreational Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recreational Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recreational Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Recreational Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Recreational Drug industry.
Chapter 3: Detailed analysis of Recreational Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Recreational Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Recreational Drug in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Inhalants
- Euphoriants
- Stimulants
- Depressants
- Hallucinogens
Applications
- Supermarkets
- Convenience Stores
- Others
Companies covered
- Yunnan Industrial Hemp
- Yishutang
- Suyash Herbs
- Nutiva
- North American Hemp & Grain Co
- Naturally Splendid
- Manitoba Harvest
- Jinzhou Qiaopai Biotech
- Isodiol
- Hempco
- GFR Ingredients Inc
- ENDOCA
- CW Hemp/CW Botanicals
- CV Sciences
- Canopy Growth Corporation
- BAFA neu GmbH
- Aphria
- Aos Products
- Agropro
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Recreational Drug Sales Value (2021-2032)
- 1.2.2 Global Recreational Drug Sales Volume (2021-2032)
- 1.2.3 Global Recreational Drug Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Recreational Drug Market Dynamics
- 2.1 Recreational Drug Industry Trends
- 2.2 Recreational Drug Industry Drivers
- 2.3 Recreational Drug Industry Opportunities and Challenges
- 2.4 Recreational Drug Industry Restraints
3 Recreational Drug Market by Company
- 3.1 Global Recreational Drug Company Revenue Ranking in 2025
- 3.2 Global Recreational Drug Revenue by Company (2021-2026)
- 3.3 Global Recreational Drug Sales Volume by Company (2021-2026)
- 3.4 Global Recreational Drug Average Price by Company (2021-2026)
- 3.5 Global Recreational Drug Company Ranking (2024-2026)
- 3.6 Global Recreational Drug Company Manufacturing Base and Headquarters
- 3.7 Global Recreational Drug Company Product Type and Application
- 3.8 Global Recreational Drug Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Recreational Drug Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Recreational Drug Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Recreational Drug Market by Type
- 4.1 Recreational Drug Type Introduction
- 4.1.1 Inhalants
- 4.1.2 Euphoriants
- 4.1.3 Stimulants
- 4.1.4 Depressants
- 4.1.5 Hallucinogens
- 4.2 Global Recreational Drug Sales Volume by Type
- 4.2.1 Global Recreational Drug Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Recreational Drug Sales Volume by Type (2021-2032)
- 4.2.3 Global Recreational Drug Sales Volume Share by Type (2021-2032)
- 4.3 Global Recreational Drug Sales Value by Type
- 4.3.1 Global Recreational Drug Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Recreational Drug Sales Value by Type (2021-2032)
- 4.3.3 Global Recreational Drug Sales Value Share by Type (2021-2032)
5 Recreational Drug Market by Application
- 5.1 Recreational Drug Application Introduction
- 5.1.1 Supermarkets
- 5.1.2 Convenience Stores
- 5.1.3 Others
- 5.2 Global Recreational Drug Sales Volume by Application
- 5.2.1 Global Recreational Drug Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Recreational Drug Sales Volume by Application (2021-2032)
- 5.2.3 Global Recreational Drug Sales Volume Share by Application (2021-2032)
- 5.3 Global Recreational Drug Sales Value by Application
- 5.3.1 Global Recreational Drug Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Recreational Drug Sales Value by Application (2021-2032)
- 5.3.3 Global Recreational Drug Sales Value Share by Application (2021-2032)
6 Recreational Drug Regional Sales and Value Analysis
- 6.1 Global Recreational Drug Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Recreational Drug Sales by Region (2021-2032)
- 6.2.1 Global Recreational Drug Sales by Region: 2021-2026
- 6.2.2 Global Recreational Drug Sales by Region (2027-2032)
- 6.3 Global Recreational Drug Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Recreational Drug Sales Value by Region (2021-2032)
- 6.4.1 Global Recreational Drug Sales Value by Region: 2021-2026
- 6.4.2 Global Recreational Drug Sales Value by Region (2027-2032)
- 6.5 Global Recreational Drug Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Recreational Drug Sales Value (2021-2032)
- 6.6.2 North America Recreational Drug Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Recreational Drug Sales Value (2021-2032)
- 6.7.2 Europe Recreational Drug Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Recreational Drug Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Recreational Drug Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Recreational Drug Sales Value (2021-2032)
- 6.9.2 South America Recreational Drug Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Recreational Drug Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Recreational Drug Sales Value Share by Country, 2025 VS 2032
7 Recreational Drug Country-level Sales and Value Analysis
- 7.1 Global Recreational Drug Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Recreational Drug Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Recreational Drug Sales by Country (2021-2032)
- 7.3.1 Global Recreational Drug Sales by Country (2021-2026)
- 7.3.2 Global Recreational Drug Sales by Country (2027-2032)
- 7.4 Global Recreational Drug Sales Value by Country (2021-2032)
- 7.4.1 Global Recreational Drug Sales Value by Country (2021-2026)
- 7.4.2 Global Recreational Drug Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.9.2 France Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.16.2 China Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.19.2 India Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Recreational Drug Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Recreational Drug Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Recreational Drug Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Recreational Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Yunnan Industrial Hemp
- 8.1.1 Yunnan Industrial Hemp Company Information
- 8.1.2 Yunnan Industrial Hemp Business Overview
- 8.1.3 Yunnan Industrial Hemp Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Yunnan Industrial Hemp Recreational Drug Product Portfolio
- 8.1.5 Yunnan Industrial Hemp Recent Developments
- 8.2 Yishutang
- 8.2.1 Yishutang Company Information
- 8.2.2 Yishutang Business Overview
- 8.2.3 Yishutang Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Yishutang Recreational Drug Product Portfolio
- 8.2.5 Yishutang Recent Developments
- 8.3 Suyash Herbs
- 8.3.1 Suyash Herbs Company Information
- 8.3.2 Suyash Herbs Business Overview
- 8.3.3 Suyash Herbs Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Suyash Herbs Recreational Drug Product Portfolio
- 8.3.5 Suyash Herbs Recent Developments
- 8.4 Nutiva
- 8.4.1 Nutiva Company Information
- 8.4.2 Nutiva Business Overview
- 8.4.3 Nutiva Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Nutiva Recreational Drug Product Portfolio
- 8.4.5 Nutiva Recent Developments
- 8.5 North American Hemp & Grain Co
- 8.5.1 North American Hemp & Grain Co Company Information
- 8.5.2 North American Hemp & Grain Co Business Overview
- 8.5.3 North American Hemp & Grain Co Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.5.4 North American Hemp & Grain Co Recreational Drug Product Portfolio
- 8.5.5 North American Hemp & Grain Co Recent Developments
- 8.6 Naturally Splendid
- 8.6.1 Naturally Splendid Company Information
- 8.6.2 Naturally Splendid Business Overview
- 8.6.3 Naturally Splendid Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Naturally Splendid Recreational Drug Product Portfolio
- 8.6.5 Naturally Splendid Recent Developments
- 8.7 Manitoba Harvest
- 8.7.1 Manitoba Harvest Company Information
- 8.7.2 Manitoba Harvest Business Overview
- 8.7.3 Manitoba Harvest Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Manitoba Harvest Recreational Drug Product Portfolio
- 8.7.5 Manitoba Harvest Recent Developments
- 8.8 Jinzhou Qiaopai Biotech
- 8.8.1 Jinzhou Qiaopai Biotech Company Information
- 8.8.2 Jinzhou Qiaopai Biotech Business Overview
- 8.8.3 Jinzhou Qiaopai Biotech Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Jinzhou Qiaopai Biotech Recreational Drug Product Portfolio
- 8.8.5 Jinzhou Qiaopai Biotech Recent Developments
- 8.9 Isodiol
- 8.9.1 Isodiol Company Information
- 8.9.2 Isodiol Business Overview
- 8.9.3 Isodiol Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Isodiol Recreational Drug Product Portfolio
- 8.9.5 Isodiol Recent Developments
- 8.10 Hempco
- 8.10.1 Hempco Company Information
- 8.10.2 Hempco Business Overview
- 8.10.3 Hempco Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Hempco Recreational Drug Product Portfolio
- 8.10.5 Hempco Recent Developments
- 8.11 GFR Ingredients Inc
- 8.11.1 GFR Ingredients Inc Company Information
- 8.11.2 GFR Ingredients Inc Business Overview
- 8.11.3 GFR Ingredients Inc Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.11.4 GFR Ingredients Inc Recreational Drug Product Portfolio
- 8.11.5 GFR Ingredients Inc Recent Developments
- 8.12 ENDOCA
- 8.12.1 ENDOCA Company Information
- 8.12.2 ENDOCA Business Overview
- 8.12.3 ENDOCA Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.12.4 ENDOCA Recreational Drug Product Portfolio
- 8.12.5 ENDOCA Recent Developments
- 8.13 CW Hemp/CW Botanicals
- 8.13.1 CW Hemp/CW Botanicals Company Information
- 8.13.2 CW Hemp/CW Botanicals Business Overview
- 8.13.3 CW Hemp/CW Botanicals Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.13.4 CW Hemp/CW Botanicals Recreational Drug Product Portfolio
- 8.13.5 CW Hemp/CW Botanicals Recent Developments
- 8.14 CV Sciences
- 8.14.1 CV Sciences Company Information
- 8.14.2 CV Sciences Business Overview
- 8.14.3 CV Sciences Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.14.4 CV Sciences Recreational Drug Product Portfolio
- 8.14.5 CV Sciences Recent Developments
- 8.15 Canopy Growth Corporation
- 8.15.1 Canopy Growth Corporation Company Information
- 8.15.2 Canopy Growth Corporation Business Overview
- 8.15.3 Canopy Growth Corporation Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Canopy Growth Corporation Recreational Drug Product Portfolio
- 8.15.5 Canopy Growth Corporation Recent Developments
- 8.16 BAFA neu GmbH
- 8.16.1 BAFA neu GmbH Company Information
- 8.16.2 BAFA neu GmbH Business Overview
- 8.16.3 BAFA neu GmbH Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.16.4 BAFA neu GmbH Recreational Drug Product Portfolio
- 8.16.5 BAFA neu GmbH Recent Developments
- 8.17 Aphria
- 8.17.1 Aphria Company Information
- 8.17.2 Aphria Business Overview
- 8.17.3 Aphria Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Aphria Recreational Drug Product Portfolio
- 8.17.5 Aphria Recent Developments
- 8.18 Aos Products
- 8.18.1 Aos Products Company Information
- 8.18.2 Aos Products Business Overview
- 8.18.3 Aos Products Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Aos Products Recreational Drug Product Portfolio
- 8.18.5 Aos Products Recent Developments
- 8.19 Agropro
- 8.19.1 Agropro Company Information
- 8.19.2 Agropro Business Overview
- 8.19.3 Agropro Recreational Drug Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Agropro Recreational Drug Product Portfolio
- 8.19.5 Agropro Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Recreational Drug Value Chain Analysis
- 9.1.1 Recreational Drug Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Recreational Drug Sales Mode & Process
- 9.2 Recreational Drug Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Recreational Drug Distributors
- 9.2.3 Recreational Drug Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst